首页> 外文期刊>Human Genetics >Identification of susceptibility genes for complex diseases using pooling-based genome-wide association scans.
【24h】

Identification of susceptibility genes for complex diseases using pooling-based genome-wide association scans.

机译:使用基于池的全基因组关联扫描识别复杂疾病的易感基因。

获取原文
获取原文并翻译 | 示例
       

摘要

The success of genome-wide association studies (GWAS) to identify risk loci of complex diseases is now well-established. One persistent major hurdle is the cost of those studies, which make them beyond the reach of most research groups. Performing GWAS on pools of DNA samples may be an effective strategy to reduce the costs of these studies. In this study, we performed pooling-based GWAS with more than 550,000 SNPs in two case-control cohorts consisting of patients with Type II diabetes (T2DM) and with chronic rhinosinusitis (CRS). In the T2DM study, the results of the pooling experiment were compared to individual genotypes obtained from a previously published GWAS. TCF7L2 and HHEX SNPs associated with T2DM by the traditional GWAS were among the top ranked SNPs in the pooling experiment. This dataset was also used to refine the best strategy to correctly identify SNPs that will remain significant based on individual genotyping. In the CRS study, the top hits from the pooling-based GWAS located within ten kilobases of known genes were validated by individual genotyping of 1,536 SNPs. Forty-one percent (598 out of the 1,457 SNPs that passed quality control) were associated with CRS at a nominal P value of 0.05, confirming the potential of pooling-based GWAS to identify SNPs that differ in allele frequencies between two groups of subjects. Overall, our results demonstrate that a pooling experiment on high-density genotyping arrays can accurately determine the minor allelic frequency as compared to individual genotyping and produce a list of top ranked SNPs that captures genuine allelic differences between a group of cases and controls. The low cost associated with a pooling-based GWAS clearly justifies its use in screening for genetic determinants of complex diseases.
机译:全基因组关联研究(GWAS)能够确定复杂疾病的风险基因座,目前已获得成功。这些研究的成本是一个持续存在的主要障碍,这使得它们超出了大多数研究小组的承受能力。对DNA样本库进行GWAS可能是降低这些研究成本的有效策略。在这项研究中,我们在两个病例对照队列中进行了基于合并的GWAS,其中包含超过550,000个SNP,这些队列由II型糖尿病(T2DM)和慢性鼻鼻窦炎(CRS)患者组成。在T2DM研究中,将合并实验的结果与从先前发表的GWAS获得的单个基因型进行了比较。通过传统GWAS与T2DM相关联的TCF7L2和HHEX SNP在合并实验中排名最高。该数据集还被用于完善最佳策略,以根据个体基因分型正确识别仍将具有重要意义的SNP。在CRS研究中,通过对1536个SNP的个体基因分型,验证了位于已知基因10公里内的基于池的GWAS的热门命中。 41%(通过质量控制的1457个SNP中的598个)与CRS的相关性为标称P值0.05,这证实了基于合并的GWAS识别两组受试者等位基因频率不同的SNP的潜力。总的来说,我们的结果表明,与单个基因分型相比,在高密度基因分型阵列上进行的合并实验可以准确确定次要等位基因频率,并产生可捕获一组病例和对照之间真正的等位基因差异的排名最高的SNP。与基于池的GWAS相关的低成本显然证明了其在筛查复杂疾病的遗传决定因素方面的合理性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号